Andrew Bouldin – Startup Investor Profile

Andrew Bouldin serves as Principal at FCA Venture Partners. FCA’s investment thesis focuses on the importance of AI in healthcare for a more efficient, personalized, and accessible future. The firm targets healthcare and digital media startups and typically invests $3 to $6 million in companies. FCA VII, a $90M early-stage venture fund, has commitments from leading health systems and individual investors. The fund invests $3-6 million in 5-6 innovative healthcare companies across Series A and Series B stages. Andrew Bouldin’s partnership and collaboration styles involve actively investing out of FCA Health Innovations II, a $71 million seed stage fund, and making strategic collaborations to enhance healthcare technologies.

Location: Brentwood, TN

Country: United States of America

Investment Regions:

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Found evidence that Andrew Bouldin (FCA Venture Partners) participated in or was associated with the Series A financing for PrecisionGx announced June 7, 2022. The last known investment activity found is June 7, 2022, which is more than 12 months ago but less than 36 months – specifically about 40 months before the reference date, indicating inactivity beyond 12 months. However, also found page dated July 25, 2022 referencing the announcement. Because the most recent verifiable investment is June/July 2022, that places the last investment more than 12 months ago. According to the definitions, that corresponds to “low-active”.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.